Behavioral family counseling and naltrexone for male opioid-dependent patients

J Consult Clin Psychol. 2003 Jun;71(3):432-42. doi: 10.1037/0022-006x.71.3.432.


Men (N = 124) entering treatment for opioid dependence who were living with a family member were randomly assigned to one of two 24-week treatments: (a) behavioral family counseling (BFC) plus individual treatment (patients had both individual and family sessions and took naltrexone daily in presence of family member) or (b) individual-based treatment only (IBT; patients were given naltrexone and were asked in counseling sessions about their compliance, but there was no family involvement). BFC patients, compared with their IBT counterparts, ingested more doses of naltrexone, attended more scheduled treatment sessions, had more days abstinent from opioids and other drugs during treatment and during the year after treatment, and had fewer drug-related, legal, and family problems at 1-year follow-up.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Behavior Therapy / methods*
  • Counseling*
  • Diagnostic and Statistical Manual of Mental Disorders
  • Family Therapy / methods*
  • Humans
  • Male
  • Naltrexone / therapeutic use*
  • Narcotic Antagonists / therapeutic use*
  • Opioid-Related Disorders / diagnosis
  • Opioid-Related Disorders / drug therapy
  • Opioid-Related Disorders / therapy*


  • Narcotic Antagonists
  • Naltrexone